50 Studies Every Urologist Should Know
50 Studies Every Urologist Should Know presents key studies that have shaped the practice of urology. Selected using a rigorous methodology, the studies cover topics including reflux disease in paediatric urology, management of male erectile dysfunction and lower urinary tract symptoms, female urology and stone disease, the various forms of genitourinary cancer, and more. For each study, a concise summary is presented with an emphasis on the results and limitations of the study, and its implications for practice. An illustrative clinical case concludes each review, followed by brief information on other relevant studies. This book is a must-read for healthcare professionals in urology, as well as anyone who wants to learn more about the data behind clinical practice.
1138618716
50 Studies Every Urologist Should Know
50 Studies Every Urologist Should Know presents key studies that have shaped the practice of urology. Selected using a rigorous methodology, the studies cover topics including reflux disease in paediatric urology, management of male erectile dysfunction and lower urinary tract symptoms, female urology and stone disease, the various forms of genitourinary cancer, and more. For each study, a concise summary is presented with an emphasis on the results and limitations of the study, and its implications for practice. An illustrative clinical case concludes each review, followed by brief information on other relevant studies. This book is a must-read for healthcare professionals in urology, as well as anyone who wants to learn more about the data behind clinical practice.
48.99 In Stock
50 Studies Every Urologist Should Know

50 Studies Every Urologist Should Know

50 Studies Every Urologist Should Know

50 Studies Every Urologist Should Know

Paperback

$48.99 
  • SHIP THIS ITEM
    Qualifies for Free Shipping
  • PICK UP IN STORE
    Check Availability at Nearby Stores

Related collections and offers


Overview

50 Studies Every Urologist Should Know presents key studies that have shaped the practice of urology. Selected using a rigorous methodology, the studies cover topics including reflux disease in paediatric urology, management of male erectile dysfunction and lower urinary tract symptoms, female urology and stone disease, the various forms of genitourinary cancer, and more. For each study, a concise summary is presented with an emphasis on the results and limitations of the study, and its implications for practice. An illustrative clinical case concludes each review, followed by brief information on other relevant studies. This book is a must-read for healthcare professionals in urology, as well as anyone who wants to learn more about the data behind clinical practice.

Product Details

ISBN-13: 9780190655341
Publisher: Oxford University Press
Publication date: 03/12/2021
Series: Fifty Studies Every Doctor Should Know
Pages: 320
Product dimensions: 9.10(w) x 6.10(h) x 0.80(d)

About the Author

Philipp Dahm is currently Professor of Urology at the University of Minnesota and Director of Research and Education for Surgical Services at the Minneapolis Veterans Administration Health Care System. Dr. Dahm completed his residency training at Duke University in Durham, North Carolina where he subsequently joined the faculty and completed a Master of Health Sciences in Clinical Research. From 2006 - 2014 he was Associate and then Full Professor in the Department of Urology at the University of Florida (UF) in Gainesville, Florida, as well as in the later years, Residency Program Director.

Table of Contents

Foreword xi

Preface from the Series Editor xiii

Contributors xv

1 Early Detection of Prostate Cancer: The European Randomized Study of Screening for Prostate Cancer (ERSPC) Philipp Dahm 1

2 The Influence of Finasteride on the Development of Prostate Cancer: Prostate Cancer Prevention Trial (PCPT) Niranjan Sathianathen 7

3 MRI-Targeted or Standard Biopsy for Prostate Cancer Diagnosis: The PRECISION Trial Philipp Dahm 13

4 Long-Term Survival Among Men With Conservatively Treated Localized Prostate Cancer: Conservative Management of Prostate Cancer Niranjan Sathianathen Philipp Dahm 19

5 Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer Niranjan Sathianathen 25

6 Radical Prostatectomy Versus Observation in Early Prostate Cancer: Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) Philipp Dahm 31

7 Radical Prostatectomy Versus Observation for Localized Prostate Cancer: The Prostate Cancer Intervention Versus Observation Trial (PIVOT) Philipp Dahm 37

8 10-Year Outcomes After Monitoring, Surgery, or Radiotherapy: The Prostate Testing for Cancer and Treatment (ProtecT) Trial Philipp Dahm 43

9 Comparative Effectiveness of Minimally Invasive Versus Open Radical Prostatectomy Philipp Dahm 49

10 Quality of Life and Satisfaction With Outcome Among Prostate Cancer Survivors: Quality of Life After Primary Treatment of Localized Prostate Cancer Niranjan Sathianathen Philipp Dahm 55

11 Adjuvant Radiotherapy for Pathologically Advanced Prostate Cancer: A Southwest Oncology Group Randomized Controlled Trial (SWOG 8794) Philipp Dahm 61

12 Survival Following Primary Androgen Deprivation Therapy Among Men With Localized Prostate Cancer Joseph Zabell 67

13 Bilateral Orchiectomy With or Without Flutamide for Metastatic Prostate Cancer Philipp Dahm 73

14 Intermittent Versus Continuous Androgen Deprivation in Prostate Cancer: Intermittent Androgen Deprivation Therapy (SWOG Trial 9346) Niranjan Sathianathen Philipp Dahm 77

15 Docetaxel Plus Prednisone or Mitoxantrone Plus Prednisone for Advanced Prostate Cancer: The TAX 327 Trial Joseph Zabell 83

16 Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: The Chemohormonal Therapy Versus Androgen Ablation Randomized Trial for Extensive Disease in Prostate Cancer (CHAARTED) Trial Philipp Dahm 89

17 Abiraterone and Increased Survival in Metastatic Prostate Cancer Joseph Zabell 95

18 Enzalutamide in Metastatic Prostate Cancer Before Chemotherapy: The PREVAIL Study Joseph Zabell 101

19 The EORTC Intergroup Phase 3 Study Comparing the Oncological Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma Christopher Weight 107

20 Nephrectomy Followed by Interferon Alfa-2b Compared With Interferon Alfa-2b Alone for Metastatic Renal Cell Cancer Christopher Weight 113

21 Sunitinib Versus Interferon Alfa in Metastatic Renal Cell Carcinoma Christopher Weight 119

22 Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma: CheckMate 025 Christopher Weight 123

23 The Effect of Intravesical Mitomycin C on Recurrence of Newly Diagnosed Superficial Bladder Cancer: A Further Report With 7 Years of Follow-Up Vikram M. Narayan 129

24 Bacillus Calmette-Guérin (BCG) Immunotherapy for Recurrent Noninvasive Transitional Cell Carcinoma of the Bladder: A Randomized Southwest Oncology Group (SWOG) Study Vikram M. Narayan 135

25 Neoadjuvant Chemotherapy Plus Cystectomy Compared With Cystectomy Alone for Locally Advanced Bladder Cancer Vikram M. Narayan 141

26 Radiotherapy With or Without Chemotherapy in Muscle-Invasive Bladder Cancer Vikram M. Narayan 147

27 A Randomized Comparison of Cisplatin Alone or in Combination With Methotrexate, Vinblastine, and Doxorubicin in Patients With Metastatic Urothelial Carcinoma: A Cooperative Group Study Philipp Dahm Vikram M. Narayan 153

28 Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study Vikram M. Narayan 159

29 Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma: KEYNOTE-045 Philipp Dahm Vikram M. Narayan 165

30 Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular Cancer Michael Risk 171

31 Treatment of Disseminated Germ Cell Tumors With Cisplatin, Bleomycin, and Either Vinblastine or Etoposide: PVB Versus BEP Michael Risk 177

32 Urinary Volume, Water Intake, and Stone Recurrence in Idiopathic Calcium Nephrolithiasis: A 5-Year Randomized Prospective Study Michael S. Borofsky Vincent G. Bird 183

33 A Prospective Study of Dietary Calcium and Other Nutrients and the Risk of Symptomatic Kidney Stones Michael S. Borofsky Vincent G. Bird 189

34 First Clinical Experience With Extra corporeally Induced Destruction of Kidney Stones by Shock Waves Michael S. Borofsky Vincent G. Bird 193

35 Shock Wave Lithotripsy Versus Ureteroscopy for Lower-Pole Caliceal Calculi 1 cm or Less Vincent G. Bird Michael S. Borofsky 197

36 Extracorporeal Shock Wave Lithotripsy Versus Percutaneous Nephrolithotomy for Lower-Pole Nephrolithiasis: The Lower Pole I Study Vincent G. Bird Michael S. Borofsky 203

37 Medical Expulsive Therapy (MET) in Adults With Ureteric Colic: The Spontaneous Urinary Stone Passage Enabled by Drugs (SUSPEND) Trial Michael S. Borofsky Vincent G. Bird 209

38 Burch Colposuspension Versus Fascial Sling to Reduce Urinary Stress Incontinence: The Stress Incontinence Surgical Treatment Efficacy (SISTEr) Trial Colby A. Dixon Giulia I. Lane Cynthia S. Fok M. Louis Moy 215

39 Retropubic Versus Transobturator Midurethral Slings for Stress Incontinence: The Trial of Mid Urethral Slings (TOMUS) Giulia I. Lane Colby A. Dixon M. Louis Moy Cynthia S. Fok 221

40 A Midurethral Sling to Reduce Incontinence After Vaginal Prolapse Repair: The Outcomes Following Vaginal Prolapse Repair and Midurethral Sling (OPUS) Trial Giulia I. Lane Colby A. Dixon M. Louis Moy Cynthia S. Fok 227

41 A Randomized Trial of Urodynamic Testing Before Stress Incontinence Surgery: The Value of Urodynamic Evaluation (ValUE) Trial Colby A. Dixon Giulia I. Lane Cynthia S. Fok M. Louis Moy 233

42 Anticholinergic Therapy Versus Onabotulinumtoxin A for Urgency Urinary Incontinence: The Anticholinergic Versus Botulinum Toxin Comparison (ABC) Study Giulia I. Lane Colby A. Dixon M. Louis Moy Cynthia S. Fok 239

43 Oral Sildenafil in the Treatment of Erectile Dysfunction Joshua Bodie 245

44 Treatment of Men With Erectile Dysfunction With Transurethral Alprostadil Joshua Bodie 251

45 Antimicrobial Prophylaxis for Children With Vesicoureteral Reflux: Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) Trial Philipp Dahm Jane M. Lewis 257

46 A Comparison of Transurethral Surgery With Watchful Waiting for Moderate Symptoms of Benign Prostatic Hyperplasia: The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate Jae Hung Jung 263

47 The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic Hyperplasia: The Veterans Affairs Cooperative Benign Prostatic Hyperplasia Study Jae Hung Jung 269

48 Chlorhexidine-Alcohol Versus Povidone-Iodine for Surgical-Site Antisepsis Philipp Dahm 275

49 Clean Intermittent Self-Catheterization in the Treatment of Urinary Tract Disease Jeffrey I. Estrin Sean P. Elliott 281

50 The Surgical Learning Curve for Prostate Cancer Control After Radical Prostatectomy Philipp Dahm 287

Index 293

From the B&N Reads Blog

Customer Reviews